{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:33:49Z","timestamp":1793126029800,"version":"4.5.0"},"reference-count":207,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jconrel.2026.115465","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T23:09:30Z","timestamp":1792537770000},"page":"115465","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"PA","title":["Engineering whole tumor cell vaccines for cancer immunotherapy: From malignant cells to therapeutic vaccines"],"prefix":"10.1016","volume":"400","author":[{"given":"Chuhan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongyu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xilin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingsheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.115465_bb0005","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/s41423-024-01207-0","article-title":"CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors","volume":"21","author":"Peng","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jconrel.2026.115465_bb0010","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/s41571-022-00689-z","article-title":"Clinical implications of T cell exhaustion for cancer immunotherapy","volume":"19","author":"Chow","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.115465_bb0015","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","article-title":"Delivery technologies for cancer immunotherapy","volume":"18","author":"Riley","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.115465_bb0020","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ymthe.2020.09.038","article-title":"Personalized cancer vaccines: clinical landscape, challenges, and opportunities","volume":"29","author":"Shemesh","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2026.115465_bb0025","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41568-021-00346-0","article-title":"Therapeutic cancer vaccines","volume":"21","author":"Saxena","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.115465_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2024.101324","article-title":"Cancer vaccines: target antigens, vaccine platforms and preclinical models","volume":"101","author":"Ruzzi","year":"2025","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.jconrel.2026.115465_bb0035","doi-asserted-by":"crossref","first-page":"512","DOI":"10.3390\/pharmaceutics14030512","article-title":"Nonviral delivery systems of mRNA vaccines for cancer gene therapy","volume":"14","author":"Wang","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115465_bb0040","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jconrel.2024.04.039","article-title":"Emerging advances in delivery systems for mRNA cancer vaccines","volume":"370","author":"Jiang","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115465_bb0045","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jconrel.2020.08.023","article-title":"Dp7-c-modified liposomes enhance immune responses and the antitumor effect of a neoantigen-based mRNA vaccine","volume":"328","author":"Zhang","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115465_bb0050","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1158\/2159-8290.CD-20-1575","article-title":"Exploiting tumor neoantigens to target cancer evolution: current challenges and promising therapeutic approaches","volume":"11","author":"Gupta","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jconrel.2026.115465_bb0055","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13045-022-01247-x","article-title":"Cancer vaccines as promising immuno-therapeutics: platforms and current progress","volume":"15","author":"Liu","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2026.115465_bb0060","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jconrel.2022.02.027","article-title":"Aluminum nanoparticles deliver a dual-epitope peptide for enhanced anti-tumor immunotherapy","volume":"344","author":"Bai","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115465_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101098","article-title":"Application of biomimetic nanovaccines in cancer immunotherapy: a useful strategy to help combat immunotherapy resistance","volume":"75","author":"Xu","year":"2024","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.jconrel.2026.115465_bb0070","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3390\/vaccines3020344","article-title":"Whole tumor antigen vaccines: where are we?","volume":"3","author":"Chiang","year":"2015","journal-title":"Vaccines"},{"key":"10.1016\/j.jconrel.2026.115465_bb0075","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s00262-008-0536-z","article-title":"Whole-cell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccines","volume":"57","author":"de Gruijl","year":"2008","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.jconrel.2026.115465_bb0080","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s41416-023-02327-6","article-title":"Whole tumour cell-based vaccines: tuning the instruments to orchestrate an optimal antitumour immune response","volume":"129","author":"P\u00e9rez-Ba\u00f1os","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2026.115465_bb0085","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.3390\/vaccines9121490","article-title":"Vaccine technologies and platforms for infectious diseases: current progress, challenges, and opportunities","volume":"9","author":"Ghattas","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.jconrel.2026.115465_bb0090","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13045-025-01670-w","article-title":"Cancer vaccines: current status and future directions","volume":"18","author":"Zhou","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2026.115465_bb0095","first-page":"491","article-title":"Engineered tumor cell-derived vaccines against cancer: the art of combating poison with poison","volume":"22","author":"Zhang","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2026.115465_bb0100","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1038\/s41423-020-0456-1","article-title":"Oxidized mitochondrial DNA sensing by STING signaling promotes the antitumor effect of an irradiated immunogenic cancer cell vaccine","volume":"18","author":"Fang","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jconrel.2026.115465_bb0105","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.3390\/vaccines11071254","article-title":"Introduction of an ultraviolet C-irradiated 4T1 murine breast cancer whole-cell vaccine model","volume":"11","author":"Szebeni","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.jconrel.2026.115465_bb0110","doi-asserted-by":"crossref","first-page":"2205462","DOI":"10.1002\/adma.202205462","article-title":"Walking dead tumor cells for targeted drug delivery against lung metastasis of triple-negative breast cancer","volume":"34","author":"Zhao","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115465_bb0115","first-page":"326","article-title":"Cryo-shocked cancer cell microgels for tumor postoperative combination immunotherapy and tissue regeneration","volume":"28","author":"Kuang","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2026.115465_bb0120","doi-asserted-by":"crossref","first-page":"36915","DOI":"10.1021\/acsnano.5c07598","article-title":"Calreticulin enhances therapeutic immune responses of dry thermostat-stressed hepatocellular carcinoma cell vaccine","volume":"19","author":"Zhang","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115465_bb0125","article-title":"Advanced oxidation nanoprocessing boosts immunogenicity of whole tumor cells","volume":"10","author":"Zhang","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.115465_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.mattod.2026.103228","article-title":"Haptenized whole tumor cell vaccines for cancer immunotherapy","volume":"94","author":"Chen","year":"2026","journal-title":"Mater. Today"},{"key":"10.1016\/j.jconrel.2026.115465_bb0135","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/s41590-019-0500-4","article-title":"Multiplexed activation of endogenous genes by CRISPRa elicits potent antitumor immunity","volume":"20","author":"Wang","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2026.115465_bb0140","article-title":"Metal-phenolic nanocloaks on cancer cells potentiate STING pathway activation for synergistic cancer immunotherapy","volume":"63","author":"He","year":"2024","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2026.115465_bb0145","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41551-021-00795-w","article-title":"Cancer vaccines from cryogenically silicified tumour cells functionalized with pathogen-associated molecular patterns","volume":"6","author":"Guo","year":"2022","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.115465_bb0150","doi-asserted-by":"crossref","first-page":"7923","DOI":"10.1021\/acsnano.3c09871","article-title":"Self-metallized whole cell vaccines prepared by microfluidics for bioorthogonally catalyzed antitumor immunotherapy","volume":"18","author":"Zeng","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115465_bb0155","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005862","article-title":"Senescent cancer cell vaccines induce cytotoxic T cell responses targeting primary tumors and disseminated tumor cells","volume":"11","author":"Liu","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2026.115465_bb0160","article-title":"Harnessing enucleated cancer cells as trojan horse cell vaccines","volume":"5","author":"Fang","year":"2024","journal-title":"Cell Rep. Phys. Sci."},{"key":"10.1016\/j.jconrel.2026.115465_bb0165","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abo4778","article-title":"Bifunctional cancer cell-based vaccine concomitantly drives direct tumor killing and antitumor immunity","volume":"15","author":"Chen","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2026.115465_bb0170","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41590-019-0561-4","article-title":"Immunological impact of cell death signaling driven by radiation on the tumor microenvironment","volume":"21","author":"Rodriguez-Ruiz","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2026.115465_bb0175","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.immuni.2022.06.007","article-title":"Oxidized DNA fragments exit mitochondria via mPTP-and VDAC-dependent channels to activate NLRP3 inflammasome and interferon signaling","volume":"55","author":"Xian","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2026.115465_bb0180","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41568-020-0246-1","article-title":"Inflammatory microenvironment remodelling by tumour cells after radiotherapy","volume":"20","author":"McLaughlin","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.115465_bb0185","doi-asserted-by":"crossref","first-page":"2213132","DOI":"10.1080\/2162402X.2023.2213132","article-title":"Augmented interferon regulatory factor 7 axis in whole tumor cell vaccines prevents tumor recurrence by inducing interferon gamma-secreting B cells","volume":"12","author":"Kajihara","year":"2023","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jconrel.2026.115465_bb0190","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1039\/D5MH01849H","article-title":"Development of a whole cell vaccine to activate dendritic cells using polyvalent CpG","volume":"13","author":"Han","year":"2026","journal-title":"Mater. Horiz."},{"key":"10.1016\/j.jconrel.2026.115465_bb0195","doi-asserted-by":"crossref","DOI":"10.4161\/21624011.2014.968434","article-title":"Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy","volume":"3","author":"Adkins","year":"2014","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jconrel.2026.115465_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cryobiol.2013.11.001","article-title":"Mechanisms of cryoablation: clinical consequences on malignant tumors","volume":"68","author":"Baust","year":"2014","journal-title":"Cryobiology"},{"key":"10.1016\/j.jconrel.2026.115465_bb0205","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2520276123","article-title":"Oocyte-inspired universal whole-cell vaccines against tumor heterogeneity","volume":"123","author":"Guo","year":"2026","journal-title":"PNAS"},{"key":"10.1016\/j.jconrel.2026.115465_bb0210","doi-asserted-by":"crossref","first-page":"21861","DOI":"10.1021\/acsami.6c04726","article-title":"Inhalable cryo-shocked tumor cells for synergistic chemoimmunotherapy","volume":"18","author":"Li","year":"2026","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2026.115465_bb0215","doi-asserted-by":"crossref","first-page":"eabc3013","DOI":"10.1126\/sciadv.abc3013","article-title":"Cryo-shocked cancer cells for targeted drug delivery and vaccination","volume":"6","author":"Ci","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.115465_bb0220","doi-asserted-by":"crossref","first-page":"63116","DOI":"10.1021\/acsami.5c17360","article-title":"Cryo-shocked cancer cell biomimetic carriers enhance tumor-targeted doxorubicin delivery in triple-negative breast cancer","volume":"17","author":"Wang","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2026.115465_bb0225","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1039\/D3BM00854A","article-title":"Immunogenic dead cells engineered by the sequential treatment of ultraviolet irradiation\/cryo-shocking for lung-targeting delivery and tumor vaccination","volume":"12","author":"Zang","year":"2024","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2026.115465_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtherbio.2020.102615","article-title":"Hyperthermia and protein homeostasis: Cytoprotection and cell death","volume":"91","author":"Ahmed","year":"2020","journal-title":"J. Therm. Biol."},{"key":"10.1016\/j.jconrel.2026.115465_bb0235","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1158\/1078-0432.CCR-10-2384","article-title":"Heat-shock induction of tumor-derived danger signals mediates rapid monocyte differentiation into clinically effective dendritic cells","volume":"17","author":"Aguilera","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.115465_bb0240","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1311433","article-title":"Severe, but not mild heat-shock treatment induces immunogenic cell death in cancer cells","volume":"6","author":"Adkins","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jconrel.2026.115465_bb0245","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201800678","article-title":"Photothermal therapy generates a thermal window of immunogenic cell death in neuroblastoma","volume":"14","author":"Sweeney","year":"2018","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2026.115465_bb0250","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s11426-025-2845-7","article-title":"The programmable whole tumor cell vaccine with multiple immunogenicity enhancement strategies for high-efficiency antitumor immunotherapy","volume":"69","author":"Meng","year":"2026","journal-title":"Sci. China Chem."},{"key":"10.1016\/j.jconrel.2026.115465_bb0255","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/02656736.2019.1663280","article-title":"In-situ vaccination using focused ultrasound heating and anti-CD-40 agonistic antibody enhances T-cell mediated local and abscopal effects in murine melanoma","volume":"36","author":"Singh","year":"2019","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.jconrel.2026.115465_bb0260","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.addr.2014.03.004","article-title":"Ultrasound induced cancer immunotherapy","volume":"72","author":"Unga","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115465_bb0265","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1039\/D1BM00542A","article-title":"Near infrared light activation of an injectable whole-cell cancer vaccine for cancer immunoprophylaxis and immunotherapy","volume":"9","author":"Wang","year":"2021","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2026.115465_bb0270","doi-asserted-by":"crossref","first-page":"21468","DOI":"10.1021\/acsnano.5c02569","article-title":"Magnetic microcarrier-based whole tumor cell vaccines for tumor prevention and immunotherapy","volume":"19","author":"Wu","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115465_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2026.189640","article-title":"Programming regulated cell death to engineer whole-tumor-cell vaccines for cancer immunotherapy","volume":"1881","author":"Guan","year":"2026","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.115465_bb0290","article-title":"Photodynamic therapy derived personalized whole cell tumor vaccine prevents postsurgery tumor recurrence and metastasis","volume":"20","author":"Yang","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2026.115465_bb0280","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba4024","article-title":"Engineering autologous tumor cell vaccine to locally mobilize antitumor immunity in tumor surgical bed","volume":"6","author":"Fang","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.115465_bb0285","doi-asserted-by":"crossref","first-page":"10923","DOI":"10.1039\/D3TB01538F","article-title":"Manganese-mineralized cancer cells as immunogenic cancer vaccines for tumor immunotherapy","volume":"11","author":"Liu","year":"2023","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2026.115465_bb0295","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.3390\/cells11131986","article-title":"A therapeutic whole-tumor-cell vaccine covalently conjugated with a TLR7 agonist","volume":"11","author":"Chi","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jconrel.2026.115465_bb0300","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.3390\/vaccines11081330","article-title":"Developing effective cancer vaccines using rendered-inactive tumor cells","volume":"11","author":"Zhao","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.jconrel.2026.115465_bb0305","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.jconrel.2024.10.060","article-title":"A personalized vaccine combining immunogenic cell death-induced cells and nanosized antigens for enhanced antitumor immunity","volume":"376","author":"Yang","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115465_bb0310","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.actbio.2023.02.012","article-title":"NIR-II light evokes DNA cross-linking for chemotherapy and immunogenic cell death","volume":"160","author":"Huang","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2026.115465_bb0315","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00775-019-01673-2","article-title":"Regulations of organism by materials: a new understanding of biological inorganic chemistry","volume":"24","author":"Lin","year":"2019","journal-title":"J. Biol. Inorg. Chem."},{"key":"10.1016\/j.jconrel.2026.115465_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2026.217574","article-title":"Multicomponent metal-organic frameworks: structural diversity and functional synergy through mixed metals and ligands in biomedical applications","volume":"553","author":"Cheng","year":"2026","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jconrel.2026.115465_bb0325","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202101391","article-title":"Cell-selective encapsulation within metal-organic framework shells via precursor-functionalized aptamer identification for whole-cell cancer vaccine","volume":"6","author":"Yang","year":"2022","journal-title":"Small Methods"},{"key":"10.1016\/j.jconrel.2026.115465_bb0330","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jconrel.2019.02.035","article-title":"An aluminum adjuvant-integrated nano-MOF as antigen delivery system to induce strong humoral and cellular immune responses","volume":"300","author":"Zhong","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115465_bb0335","doi-asserted-by":"crossref","first-page":"2412950","DOI":"10.1002\/adfm.202412950","article-title":"Bioinspired green underwater adhesive gelatin-tannic acid hydrogel with wide range adjustable adhesion strength and multiple environmental adaptability","volume":"35","author":"Yuan","year":"2025","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2026.115465_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2025.169504","article-title":"Investigation of the impact of local tumor phenolic-chemistry for dual starvation and vaccination therapy","volume":"524","author":"Lu","year":"2025","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.jconrel.2026.115465_bb0365","doi-asserted-by":"crossref","first-page":"9702","DOI":"10.1021\/acs.nanolett.5c01666","article-title":"Intracellular bacteria-mimicking whole-cell cancer vaccine potentiates immune responses via concurrent activation of NLRP3 inflammasome and STING pathway","volume":"25","author":"Xie","year":"2025","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2026.115465_bb0345","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.actbio.2020.06.038","article-title":"Improvement of organisms by biomimetic mineralization: a material incorporation strategy for biological modification","volume":"120","author":"Zhao","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2026.115465_bb0350","doi-asserted-by":"crossref","first-page":"13661","DOI":"10.1002\/anie.201706910","article-title":"Manganese dioxide nanozymes as responsive cytoprotective shells for individual living cell encapsulation","volume":"56","author":"Li","year":"2017","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2026.115465_bb0355","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/978-1-0716-3469-1_15","article-title":"Cancer cell silicification and surface functionalization to create microbial mimetic cancer vaccines","volume":"2720","author":"Medina","year":"2024","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jconrel.2026.115465_bb0360","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1039\/D5BM00914F","article-title":"Construction strategies of whole tumor cell vaccines","volume":"13","author":"Wang","year":"2025","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2026.115465_bb0370","doi-asserted-by":"crossref","first-page":"19901","DOI":"10.1021\/acsnano.5c02846","article-title":"Multimodal regulation of dendritic cells via mineralized vaccines for postsurgical tumor relapse prevention","volume":"19","author":"Gu","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115465_bb0375","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/adma.201303699","article-title":"Synthesis of metal nanoparticles inside living human cells based on the intracellular formation process","volume":"26","author":"El-Said","year":"2014","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115465_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2024.149224","article-title":"A novel biosynthesized vaccine based on tumor cells for peritoneal metastasis treatment in colon cancer","volume":"484","author":"Qin","year":"2024","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.jconrel.2026.115465_bb0385","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202303683","article-title":"Self-generating gold nanocatalysts in autologous tumor cells for targeted catalytic immunotherapy","volume":"13","author":"Zeng","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2026.115465_bb0390","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41585-023-00739-w","article-title":"Vaccines as treatments for prostate cancer","volume":"20","author":"Rastogi","year":"2023","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.jconrel.2026.115465_bb0395","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1158\/1078-0432.CCR-20-1025","article-title":"A phase II study of allogeneic GM-CSF-transfected pancreatic tumor vaccine (GVAX) with ipilimumab as maintenance treatment for metastatic pancreatic cancer","volume":"26","author":"Wu","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.115465_bb0400","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.1021\/acs.nanolett.6b02786","article-title":"Preferential cancer cell self-recognition and tumor self-targeting by coating nanoparticles with homotypic cancer cell membranes","volume":"16","author":"Zhu","year":"2016","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2026.115465_bb0405","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41581-022-00601-z","article-title":"Cellular senescence: the good, the bad and the unknown","volume":"18","author":"Huang","year":"2022","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.jconrel.2026.115465_bb0410","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41568-019-0156-2","article-title":"Unmasking senescence: context-dependent effects of SASP in cancer","volume":"19","author":"Faget","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.115465_bb0415","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1158\/2159-8290.CD-22-0528","article-title":"Senescence rewires microenvironment sensing to facilitate antitumor immunity","volume":"13","author":"Chen","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jconrel.2026.115465_bb0420","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1158\/2159-8290.CD-22-0523","article-title":"Cellular senescence is immunogenic and promotes antitumor immunity","volume":"13","author":"Marin","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jconrel.2026.115465_bb0425","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.trecan.2024.11.010","article-title":"Cellular senescence offers distinct immunological vulnerabilities in cancer","volume":"11","author":"Zhou","year":"2025","journal-title":"Trends Cancer"},{"key":"10.1016\/j.jconrel.2026.115465_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2026.128430","article-title":"Senescent cancer cell-derived vaccines: current progress, immunological challenges, and translational perspectives","volume":"79","author":"Song","year":"2026","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2026.115465_bb0435","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/s41551-021-00815-9","article-title":"Genetically engineered and enucleated human mesenchymal stromal cells for the targeted delivery of therapeutics to diseased tissue","volume":"6","author":"Wang","year":"2022","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.115465_bb0440","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1083\/jcb.201706097","article-title":"Enucleated cells reveal differential roles of the nucleus in cell migration, polarity, and mechanotransduction","volume":"217","author":"Graham","year":"2018","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jconrel.2026.115465_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.218215","article-title":"Fgl2-knockout tumor cells serve as a vaccine inducing long-duration brain-resident memory T cells that reject subsequent intracranial tumor cell challenges","volume":"640","author":"Zhang","year":"2026","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2026.115465_bb0450","article-title":"Harnessing whole tumor cells for tumor immunotherapy","volume":"1","author":"Chen","year":"2023","journal-title":"Innov. Mater."},{"key":"10.1016\/j.jconrel.2026.115465_bb0455","doi-asserted-by":"crossref","DOI":"10.1126\/science.abj4008","article-title":"CRISPR activation and interference screens decode stimulation responses in primary human T cells","volume":"375","author":"Schmidt","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.115465_bb0460","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20240959","article-title":"Mcrs1 sensitizes T cell-dependent immunotherapy by augmenting MHC-I expression in solid tumors","volume":"221","author":"Li","year":"2024","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2026.115465_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2026.124173","article-title":"An epigenetically enhanced whole-cell vaccine in a stimulatory hydrogel for robust antitumor immunity","volume":"333","author":"Li","year":"2026","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.115465_bb0475","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1021\/acsami.2c16806","article-title":"Cryo-shocked cancer cells as an oncolytic adenovirus reservoir for glioblastoma immunotherapy","volume":"15","author":"Liu","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2026.115465_bb0490","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1186\/s12967-022-03714-y","article-title":"Whole-cell tumor vaccines desialylated to uncover tumor antigenic gal\/GalNAc epitopes elicit anti-tumor immunity","volume":"20","author":"Huang","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jconrel.2026.115465_bb0470","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13045-020-00922-1","article-title":"Oncolytic viruses for cancer immunotherapy","volume":"13","author":"Hemminki","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2026.115465_bb0480","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202370197","article-title":"Inhibition of tumor metastasis by liquid-nitrogen-shocked tumor cells with oncolytic viruses infection","volume":"35","author":"Wu","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115465_bb0485","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2147\/IJN.S446919","article-title":"Opportunities and challenges for inhalable nanomedicine formulations in respiratory diseases: a review","volume":"19","author":"Feng","year":"2024","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.115465_bb0495","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1080\/14728222.2019.1667977","article-title":"The sialoglycan-siglec glyco-immune checkpoint - a target for improving innate and adaptive anti-cancer immunity","volume":"23","author":"B\u00e4renwaldt","year":"2019","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.jconrel.2026.115465_bb0500","doi-asserted-by":"crossref","first-page":"2201706","DOI":"10.1002\/adma.202201706","article-title":"Glutathione-depleting organic metal adjuvants for effective NIR-II photothermal immunotherapy","volume":"34","author":"Chen","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115465_bb0505","article-title":"Immunogenic cell death activates the tumor immune microenvironment to boost the immunotherapy efficiency","volume":"9","author":"Li","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.115465_bb0510","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.jconrel.2020.10.041","article-title":"Dendronized polymer conjugates with amplified immunogenic cell death for oncolytic immunotherapy","volume":"329","author":"Li","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115465_bb0515","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41422-020-0383-9","article-title":"Calreticulin and cancer","volume":"31","author":"Fucikova","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.jconrel.2026.115465_bb0520","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1038\/sj.cdd.4402201","article-title":"Calreticulin exposure is required for the immunogenicity of gamma-irradiation and UVC light-induced apoptosis","volume":"14","author":"Obeid","year":"2007","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jconrel.2026.115465_bb0525","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nri.2016.107","article-title":"Immunogenic cell death in cancer and infectious disease","volume":"17","author":"Galluzzi","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.115465_bb0530","doi-asserted-by":"crossref","first-page":"5229","DOI":"10.1038\/s41467-023-40935-1","article-title":"Nanocompartment-confined polymerization in living systems","volume":"14","author":"Chen","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115465_bb0535","doi-asserted-by":"crossref","first-page":"2408242","DOI":"10.1002\/adma.202408242","article-title":"Bimetal-biligand frameworks for spatiotemporal nitric oxide-enhanced sono-immunotherapy","volume":"36","author":"Cheng","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115465_bb0540","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/s41573-024-00920-9","article-title":"Targeting immunogenic cell stress and death for cancer therapy","volume":"23","author":"Galluzzi","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.115465_bb0545","article-title":"Cancer vaccine from intracellularly gelated tumor cells functionalized with CD47 blockage and damage-associated molecular pattern exposure","volume":"6","author":"Gao","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.jconrel.2026.115465_bb0550","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jconrel.2023.05.044","article-title":"Dying tumor cells-inspired vaccine for boosting humoral and cellular immunity against cancer","volume":"359","author":"Qin","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115465_bb0555","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jare.2021.03.003","article-title":"In vitro naphthylquinoxaline thymidine conjugate and UVA treated cancer cells are effective therapeutic vaccines for tumors in vivo with CpG as the adjuvant","volume":"35","author":"Yang","year":"2022","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.jconrel.2026.115465_bb0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2026.124112","article-title":"STING-activating & ICD dual-response whole tumor cell vaccine amplifies TNBC immunotherapy","volume":"331","author":"Lu","year":"2026","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.115465_bb0560","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41392-025-02140-y","article-title":"Phototherapy in cancer treatment: strategies and challenges","volume":"10","author":"Cai","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.115465_bb0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcis.2025.138488","article-title":"Generation of personalized whole tumor cells vaccine for pyroptosis-enhanced anticancer immunity via Cu2-xSe photothermal activation under NIR irradiation","volume":"700","author":"Chang","year":"2025","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2026.115465_bb0575","doi-asserted-by":"crossref","first-page":"9470","DOI":"10.7150\/thno.62984","article-title":"Ultrasound (US)-activated redox dyshomeostasis therapy reinforced by immunogenic cell death (ICD) through a mitochondrial targeting liposomal nanosystem","volume":"11","author":"Ren","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.115465_bb0580","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202413289","article-title":"Cryo-shocked tumor-reprogrammed sonosensitive antigen-presenting cells improving sonoimmunotherapy via T cells and NK cells immunity","volume":"37","author":"Qian","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115465_bb0585","doi-asserted-by":"crossref","first-page":"18100","DOI":"10.1021\/acsnano.1c06707","article-title":"Precise delivery of nanomedicines to m2 macrophages by combining \"eat me\/don't eat me\" signals and its anticancer application","volume":"15","author":"Tang","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115465_bb0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2020.101070","article-title":"Fullerenols boosting the therapeutic effect of anti-CD47 antibody to trigger robust anti-tumor immunity by inducing calreticulin exposure","volume":"37","author":"Chen","year":"2021","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2026.115465_bb0595","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ejca.2016.09.010","article-title":"Turning tumour cells into antigen presenting cells: the next step to improve cancer immunotherapy?","volume":"68","author":"de Charette","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jconrel.2026.115465_bb0600","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jconrel.2024.11.018","article-title":"Autophagy-activating aluminum hydroxide nanovaccine for enhanced antigen presentation and anti-tumor immunity","volume":"377","author":"Chen","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115465_bb0605","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41577-022-00761-w","article-title":"Tuning immunity through tissue mechanotransduction","volume":"23","author":"Du","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.115465_bb0610","article-title":"Stiffening the soft tumor: Biosilicification-enabled mechanical immune checkpoint blockade sono-immunotherapy","volume":"22","author":"Zhang","year":"2026","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2026.115465_bb0615","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41565-023-01535-8","article-title":"Evidence and therapeutic implications of biomechanically regulated immunosurveillance in cancer and other diseases","volume":"19","author":"Mittelheisser","year":"2024","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115465_bb0620","doi-asserted-by":"crossref","first-page":"28675","DOI":"10.1021\/acsnano.4c06215","article-title":"Mechanotransduction-piloted whole-cell vaccines for spatiotemporal modulation of postoperative antitumor immunity","volume":"18","author":"Gu","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115465_bb0625","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1016\/j.apsb.2023.01.006","article-title":"Advanced subunit vaccine delivery technologies: from vaccine cascade obstacles to design strategies","volume":"13","author":"Hou","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2026.115465_bb0630","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jconrel.2020.07.008","article-title":"Tumor cell membrane enveloped aluminum phosphate nanoparticles for enhanced cancer vaccination","volume":"326","author":"Gan","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115465_bb0635","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s11095-024-03665-7","article-title":"Intradermal vaccination with PLGA nanoparticles via dissolving microneedles and classical injection needles","volume":"41","author":"Lee","year":"2024","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2026.115465_bb0640","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113740","article-title":"Tough and waterproof microneedles overcome mucosal immunotolerance by modulating antigen release patterns","volume":"382","author":"He","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115465_bb0645","article-title":"Intradermal delivery of cell vaccine via ice microneedles for cancer treatment","volume":"14","author":"Yang","year":"2025","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2026.115465_bb0665","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1038\/s41467-018-03915-4","article-title":"A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors","volume":"9","author":"Wang","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115465_bb0650","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202300121","article-title":"Rethinking antigen source: cancer vaccines based on whole tumor cell\/tissue lysate or whole tumor cell","volume":"10","author":"Diao","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.115465_bb0655","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1016\/j.apsb.2024.06.003","article-title":"In situ tumor vaccine with optimized nanoadjuvants and lymph node targeting capacity to treat ovarian cancer and metastases","volume":"14","author":"Li","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2026.115465_bb0660","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122218","article-title":"Antigenicity and adjuvanticity co-reinforced personalized cell vaccines based on self-adjuvanted hydrogel for post-surgical cancer vaccination","volume":"301","author":"He","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.115465_bb0670","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/s41423-021-00753-1","article-title":"Metabolic programming in dendritic cells tailors immune responses and homeostasis","volume":"19","author":"M\u00f8ller","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jconrel.2026.115465_bb0675","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jconrel.2024.12.035","article-title":"Functionalized aluminum hydroxide-based self-adjuvanted nanovaccine orchestrates antitumor immune responses via dectin-1 signaling","volume":"378","author":"Ling","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115465_bb0680","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.tibtech.2018.10.004","article-title":"Applications of immunomodulatory immune synergies to adjuvant discovery and vaccine development","volume":"37","author":"Tom","year":"2019","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115465_bb0685","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.3390\/ijms27104271","article-title":"Vaccine adjuvants and delivery systems: a comprehensive review","volume":"27","author":"Garc\u00eda","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115465_bb0690","first-page":"924","article-title":"Biomaterials nanoplatform-based tumor vaccines for immunotherapy","volume":"51","author":"Li","year":"2025","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2026.115465_bb0695","doi-asserted-by":"crossref","first-page":"2517137","DOI":"10.1080\/10717544.2025.2517137","article-title":"Advances in vaccine adjuvant development and future perspectives","volume":"32","author":"Sinani","year":"2025","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2026.115465_bb0700","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1016\/j.apsb.2024.06.006","article-title":"Simultaneous enhancement of cellular and humoral immunity by the lymph node-targeted cholesterolized TLR7 agonist liposomes","volume":"14","author":"Wan","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2026.115465_bb0705","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jconrel.2024.09.044","article-title":"Nanomaterial-assisted delivery of CpG oligodeoxynucleotides for boosting cancer immunotherapy","volume":"376","author":"Zhang","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115465_bb0710","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jconrel.2020.06.021","article-title":"Co-delivery of antigen and dual adjuvants by aluminum hydroxide nanoparticles for enhanced immune responses","volume":"326","author":"Hou","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115465_bb0715","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1039\/D0BM01393E","article-title":"A vaccine for photodynamic immunogenic cell death: tumor cell caged by cellular disulfide-thiol exchange for immunotherapy","volume":"9","author":"Wen","year":"2021","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2026.115465_bb0720","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.ccell.2021.08.005","article-title":"Activating a collaborative innate-adaptive immune response to control metastasis","volume":"39","author":"Sun","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2026.115465_bb0725","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1016\/j.matt.2022.05.025","article-title":"Autologous whole-cell cancer vaccination: cryogenic silicified vaccines","volume":"5","author":"Chen","year":"2022","journal-title":"Matter"},{"key":"10.1016\/j.jconrel.2026.115465_bb0730","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122319","article-title":"Potentiating cancer vaccination by adjuvant-loaded cryo-shocked tumor cells","volume":"302","author":"Chen","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.115465_bb0735","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.pharmthera.2014.09.010","article-title":"Poly(I:C) as cancer vaccine adjuvant: knocking on the door of medical breakthroughs","volume":"146","author":"Ammi","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2026.115465_bb0760","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.70198","article-title":"Irradiated liver cancer cell vaccine transfected with GM-CSF induces specific and long-lasting anti-tumour immunity through the synergistic effect of oxidised mtDNA and GM-CSF","volume":"59","author":"Song","year":"2026","journal-title":"Cell Prolif."},{"key":"10.1016\/j.jconrel.2026.115465_bb0740","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.7150\/thno.121911","article-title":"A novel whole cancer cell vaccine based on modified \u03b2-glucan elicits robust anti-tumor immunity","volume":"16","author":"Huang","year":"2026","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.115465_bb0745","doi-asserted-by":"crossref","first-page":"11235","DOI":"10.1039\/D2NR02012B","article-title":"In situ release of IL-2\/IL-12 from SiO2-engineered dendritic cells for synergistic immunotherapy","volume":"14","author":"Xu","year":"2022","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2026.115465_bb0750","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s40824-023-00430-6","article-title":"GM-CSF augmented the photothermal immunotherapeutic outcome of self-driving gold nanoparticles against a mouse CT-26 colon tumor model","volume":"27","author":"Dai","year":"2023","journal-title":"Biomater. Res."},{"key":"10.1016\/j.jconrel.2026.115465_bb0755","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/med.21882","article-title":"Genetically modified cancer vaccines: current status and future prospects","volume":"42","author":"Hu","year":"2022","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jconrel.2026.115465_bb0765","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.02.056","article-title":"Advances in polymer nanomaterials targeting cGAS-STING pathway for enhanced cancer immunotherapy","volume":"381","author":"Peng","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115465_bb0770","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jconrel.2023.04.036","article-title":"A MnAl double adjuvant nanovaccine to induce strong humoral and cellular immune responses","volume":"358","author":"Qiao","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115465_bb0775","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122911","article-title":"Priming of cancer-immunity cycle by alleviating hypoxia-induced ferroptosis resistance and immunosuppression","volume":"315","author":"Chen","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.115465_bb0780","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.immuni.2024.02.019","article-title":"New frontiers in the cGAS-STING intracellular DNA-sensing pathway","volume":"57","author":"Dvorkin","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2026.115465_bb0785","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/med.22016","article-title":"cGAS-STING pathway agonists are promising vaccine adjuvants","volume":"44","author":"Tian","year":"2024","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jconrel.2026.115465_bb0790","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114129","article-title":"Co-delivery of sn38 and sr717 activates cGAS-STING for near-infrared II image-guided chemoimmunotherapy","volume":"386","author":"Hou","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115465_bb0795","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.tips.2022.08.006","article-title":"Nanodelivery of cGAS-STING activators for tumor immunotherapy","volume":"43","author":"Guo","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jconrel.2026.115465_bb0800","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41392-021-00554-y","article-title":"Cytosolic DNA sensing by cGAS: regulation, function, and human diseases","volume":"6","author":"Yu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.115465_bb0805","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/s41551-024-01221-7","article-title":"Strategies for the development of metalloimmunotherapies","volume":"8","author":"Sun","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.115465_bb0810","article-title":"Manganese galvanic cells intervene in tumor metabolism to reinforce cGAS-STING activation for bidirectional synergistic hydrogen-immunotherapy","volume":"37","author":"Yang","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115465_bb0815","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jconrel.2025.01.009","article-title":"Antigens and adjuvants co-stabilized Pickering emulsions amplify immune responses of subunit vaccines","volume":"379","author":"Guo","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115465_bb0820","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1038\/s41590-025-02308-2","article-title":"Cancer vaccines as enablers of immunotherapy","volume":"26","author":"Khleif","year":"2025","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2026.115465_bb0825","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41568-022-00491-0","article-title":"Natural killer cells in antitumour adoptive cell immunotherapy","volume":"22","author":"Laskowski","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.115465_bb0830","first-page":"239","article-title":"Linking macrophage metabolism to function in the tumor microenvironment","volume":"6","author":"Jin","year":"2025","journal-title":"Nat. Can."},{"key":"10.1016\/j.jconrel.2026.115465_bb0835","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/j.cell.2024.03.037","article-title":"Principles and therapeutic applications of adaptive immunity","volume":"187","author":"Chi","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2026.115465_bb0840","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/s41590-022-01267-2","article-title":"The complex role of tumor-infiltrating macrophages","volume":"23","author":"Christofides","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2026.115465_bb0845","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1021\/acs.biomac.5c00115","article-title":"Enhanced whole tumor cell-based vaccines by a RAFT and protein fusion strategy for tumor immunotherapy","volume":"26","author":"Yang","year":"2025","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2026.115465_bb0850","article-title":"Engineered cryo-shocked cancer cells deliver dual-function gene medicines for melanoma immunotherapy","volume":"38","author":"Liu","year":"2026","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115465_bb0855","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jconrel.2022.09.027","article-title":"A cell-laden hydrogel as prophylactic vaccine and anti-PD-L1 amplifier against autologous tumors","volume":"351","author":"Li","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115465_bb0860","doi-asserted-by":"crossref","first-page":"5405","DOI":"10.1016\/j.apsb.2026.06.001","article-title":"Universal off-the-shelf tgf-\u03b21-knockout whole-tumor cell vaccine overcomes immunotherapy resistance in pmmr\/mss tumors","volume":"16","author":"Yang","year":"2026","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2026.115465_bb0865","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12943-024-02023-w","article-title":"Regulatory mechanisms of PD-1\/PD-L1 in cancers","volume":"23","author":"Lin","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2026.115465_bb0870","article-title":"The role of immune checkpoint inhibitors in cancer therapy: mechanism and therapeutic advances","volume":"6","author":"Chen","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.jconrel.2026.115465_bb0875","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.3389\/fphar.2019.01184","article-title":"Safety and efficacy of therapeutic cancer vaccines alone or in combination with immune checkpoint inhibitors in cancer treatment","volume":"10","author":"Zhao","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.115465_bb0880","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13045-024-01581-2","article-title":"Dual blockade immunotherapy targeting PD-1\/PD-L1 and CTLA-4 in lung cancer","volume":"17","author":"Cheng","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2026.115465_bb0885","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s13046-021-01987-7","article-title":"Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer","volume":"40","author":"Zhang","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.115465_bb0890","article-title":"Blocking CTLA-4 while priming with a whole cell vaccine reshapes the oligoclonal T cell infiltrate and eradicates tumors in an orthotopic glioma model","volume":"7","author":"Field","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jconrel.2026.115465_bb0895","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cytogfr.2024.08.001","article-title":"Targeting PD-1\/PD-L1 in tumor immunotherapy: mechanisms and interactions with host growth regulatory pathways","volume":"79","author":"Shen","year":"2024","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.jconrel.2026.115465_bb0900","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s11671-021-03588-x","article-title":"Cells-based drug delivery for cancer applications","volume":"16","author":"Du","year":"2021","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.jconrel.2026.115465_bb0910","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.101920","article-title":"Targeted delivery of novel Au(I)-based AIEgen via inactivated cancer cells for trimodal chemo-radio-immunotherapy and vaccination against advanced tumor","volume":"51","author":"Duo","year":"2023","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2026.115465_bb0920","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1038\/s41467-023-40207-y","article-title":"Generation of whole tumor cell vaccine for on-demand manipulation of immune responses against cancer under near-infrared laser irradiation","volume":"14","author":"Meng","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115465_bb0930","article-title":"Cryo-shocked tumor cells deliver CRISPR-cas9 for lung cancer regression by synthetic lethality","volume":"10","author":"Liu","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.115465_bb0905","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1056\/NEJMra2506017","article-title":"Effects of radiotherapy in normal tissue","volume":"394","author":"Citrin","year":"2026","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2026.115465_bb0915","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1039\/C8CS00618K","article-title":"Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer","volume":"48","author":"Liu","year":"2019","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2026.115465_bb0925","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.apsb.2024.12.017","article-title":"NIR-II-activated whole-cell vaccine with ultra-efficient semiconducting diradical oligomers for breast carcinoma growth and metastasis inhibition","volume":"15","author":"Gao","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2026.115465_bb0935","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ccell.2022.10.001","article-title":"Multi-omic analyses of changes in the tumor microenvironment of pancreatic adenocarcinoma following neoadjuvant treatment with anti-PD-1 therapy","volume":"40","author":"Li","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2026.115465_bb0940","doi-asserted-by":"crossref","first-page":"TPS1137","DOI":"10.1200\/JCO.2024.42.16_suppl.TPS1137","article-title":"Study of the Bria-IMT regimen and cpi vs physicians' choice in advanced metastatic breast cancer (BRIA-ABC)","volume":"42","author":"Hurvitz","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.115465_bb0945","doi-asserted-by":"crossref","DOI":"10.1158\/1557-3265.SABCS25-PS1-13-23","article-title":"Abstract ps1-13-23: survival results of phase II Bria-IMT allogenic whole cell-based cancer vaccine","volume":"32","author":"Nangia","year":"2026","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.115465_bb0950","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1158\/1078-0432.CCR-24-3403","article-title":"A phase II study of neoadjuvant GVAX and cyclophosphamide combined with nivolumab and SBRT followed by surgery in borderline resectable pancreatic adenocarcinoma","volume":"31","author":"Agarwal","year":"2025","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.115465_bb0955","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/SLA.0000000000004669","article-title":"A phase 3 randomized clinical trial of chemotherapy with or without algenpantucel-l (hyperacute-pancreas) immunotherapy in subjects with borderline resectable or locally advanced unresectable pancreatic cancer","volume":"275","author":"Hewitt","year":"2022","journal-title":"Ann. Surg."},{"key":"10.1016\/j.jconrel.2026.115465_bb0960","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/S1470-2045(20)30533-7","article-title":"Gemogenovatucel-T (vigil) immunotherapy as maintenance in frontline stage iii\/iv ovarian cancer (vital): a randomised, double-blind, placebo-controlled, phase 2b trial","volume":"21","author":"Rocconi","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jconrel.2026.115465_bb0965","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1038\/s41467-023-39196-9","article-title":"A platform trial of neoadjuvant and adjuvant antitumor vaccination alone or in combination with PD-1 antagonist and CD137 agonist antibodies in patients with resectable pancreatic adenocarcinoma","volume":"14","author":"Heumann","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115465_bb0970","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.842555","article-title":"An update of cutaneous melanoma patients treated in adjuvancy with the allogeneic melanoma vaccine vaccimel and presentation of a selected case report with in-transit metastases","volume":"13","author":"Mordoh","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115465_bb0975","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s40164-025-00703-x","volume":"14","author":"Fernandez","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2026.115465_bb0980","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191712","article-title":"Autologous tumor cell vaccine induces antitumor T cell immune responses in patients with mantle cell lymphoma: a phase i\/II trial","volume":"217","author":"Frank","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2026.115465_bb0985","doi-asserted-by":"crossref","DOI":"10.4028\/b-XDTcg5","article-title":"Morphology- and adhesion-dual biomimetic nanovaccine boosts antigen cross-presentation through subcellular transport regulation","volume":"11","author":"Wang","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.115465_bb0990","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12943-023-01714-0","article-title":"Regulatory cells and the effect of cancer immunotherapy","volume":"22","author":"Iglesias-Escudero","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2026.115465_bb0995","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113603","article-title":"Myeloid-derived suppressor cell-targeted virus-like particles synergistically activate innate immune response for cancer immunotherapy","volume":"381","author":"Zhu","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115465_bb1000","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.3390\/cancers17132100","article-title":"Cancer stem cells connecting to immunotherapy: key insights, challenges, and potential treatment opportunities","volume":"17","author":"Mathan","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.jconrel.2026.115465_bb1005","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.apsb.2020.07.013","article-title":"The progress and perspective of nanoparticle-enabled tumor metastasis treatment","volume":"10","author":"Zhang","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2026.115465_bb1010","doi-asserted-by":"crossref","first-page":"20230171","DOI":"10.1002\/EXP.20230171","article-title":"Tumor cell membrane-based vaccines: a potential boost for cancer immunotherapy","volume":"4","author":"Yang","year":"2024","journal-title":"Exploration"},{"key":"10.1016\/j.jconrel.2026.115465_bb1015","doi-asserted-by":"crossref","DOI":"10.1002\/imed.1025","article-title":"Whole tumor cell vaccines engineered to secrete GM-CSF (GVAX)","volume":"1","author":"Soiffer","year":"2021","journal-title":"ImmunoMedicine"},{"key":"10.1016\/j.jconrel.2026.115465_bb1020","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1038\/s41467-025-60239-w","article-title":"A cowpea mosaic virus adjuvant conjugated to liposomes loaded with tumor cell lysates as an ovarian cancer vaccine","volume":"16","author":"Zhao","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115465_bb1025","article-title":"A hybrid eukaryotic-prokaryotic nanoplatform with photothermal modality for enhanced antitumor vaccination","volume":"32","author":"Chen","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115465_bb1030","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1038\/s44321-026-00465-x","article-title":"Bacterialized tumor cells as vaccine","volume":"18","author":"Huang","year":"2026","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.jconrel.2026.115465_bb1035","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41392-026-02769-3","article-title":"Personalized cancer vaccines: bridging immune-oncology and precision medicine for advanced therapeutics","volume":"11","author":"Ye","year":"2026","journal-title":"Signal Transduct. Target. Ther."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926008692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926008692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:51:46Z","timestamp":1793123506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926008692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":207,"alternative-id":["S0168365926008692"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115465","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineering whole tumor cell vaccines for cancer immunotherapy: From malignant cells to therapeutic vaccines","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115465","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115465"}}